Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97847613 | 9784761 | 3 | F | 20160711 | 20131227 | 20160720 | EXP | GR-AMGEN-GRCSP2013090032 | AMGEN | STERGIOS A POLYZOS, EVANGELOS TERPOS. CLINICAL VERTEBRAL FRACTURES FOLLOWING DENOSUMAB DISCONTINUATION. SPRINGER. 2016 | 61.00 | YR | A | F | Y | 0.00000 | 20160720 | MD | GR | GR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97847613 | 9784761 | 1 | PS | PROLIA | DENOSUMAB | 1 | Unknown | 60 MG, Q6MO | 125320 | 60 | MG | SOLUTION FOR INJECTION | |||||||
| 97847613 | 9784761 | 2 | C | STRONTIUM RANELATE | STRONTIUM RANELATE | 1 | UNK | 0 | |||||||||||
| 97847613 | 9784761 | 3 | C | RALOXIFENE. | RALOXIFENE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97847613 | 9784761 | 1 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97847613 | 9784761 | OT |
| 97847613 | 9784761 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97847613 | 9784761 | Spinal fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |